Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine
Author(s):
Rebecca Webster, Silvana Sekuloski, Anand Odedra, Stephen Woolley, Helen Jennings, Fiona Amante, Katharine R. Trenholme, Julie Healer, Alan F. Cowman, Emily M. Eriksson, Priyanka Sathe, Jocelyn Penington, Adam J. Blanch, Matthew W.A. Dixon, Leann Tilley, Michael F. Duffy, Alister Craig, Janet Storm, Jo Anne Chan, Krystal Evans, Anthony T. Papenfuss, Louis Schofield, Paul Griffin, Bridget E. Barber, Dean Andrew, Michelle J. Boyle, Fabian de Labastida Rivera, Christian Engwerda, James S. McCarthy
Details:
BMC Medicine, Volume 19, Issue 1, 2021-12-01, Article number 293
Article Link: Click here
Affiliations:
- University of Melbourne
- The Peter Doherty Institute for Infection and Immunity
- GlaxoSmithKline Australia Pty Ltd.
- Bio21 Molecular Science and Biotechnology Institute
- The University of Queensland
- Walter and Eliza Hall Institute of Medical Research
- QIMR Berghofer Medical Research Institute
- Liverpool School of Tropical Medicine
- James Cook University
- Queen Elizabeth Hospital Birmingham
- Royal Melbourne Hospital
- Burnet Institute
- Current address: PharmOut
- Mater Hospital and Mater Research
- Medicines Development for Global Health